Imaging-guided lung surgery using special near-infrared light
This trial tests whether using special near-infrared imaging can help surgeons better guide lung tumor removal during minimally invasive or open chest surgery. It may improve how accurately the surgical area is identified during the operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older.
- Your thoracic surgeon recommends surgery to remove a lung lesion using video-assisted chest surgery (VATS) or open surgery (thoracotomy).
- You can sign an informed consent form before any study-related tests or procedures.
- If you can become pregnant, you must have a negative pregnancy test before any study procedures.
- You must not have an iodine allergy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new device that uses augmented reality and a special dye to help surgeons find the sentinel lymph node (the first node that cancer might spread to) during breast cancer surgery. It may help make the node removal more precise and reduce unnecessary removal.
This study tests a dye that helps surgeons see the first lymph nodes during esophageal cancer surgery. It might help remove fewer lymph nodes and reduce side effects.
This trial tests using a green dye called ICG (indocyanine green) during breast cancer surgery to find the first lymph nodes (sentinel nodes) that cancer may have spread to. It aims to help doctors locate these nodes more accurately, and is for people with early-stage breast cancer that has not yet spread to the lymph nodes.
This trial tests a new way for surgeons to find leftover cancer cells in the lymph nodes after they have been removed during breast cancer surgery. It uses a special dye and augmented reality to help make sure no cancer is missed.
This study tests a special dye that helps surgeons see breast cancer tissue and nearby lymph nodes more clearly during surgery. The goal is to make sure all cancer is removed while sparing healthy tissue.
This early-stage trial tests a robotic lung surgery that uses a special dye with near-infrared light to help the surgeon remove only the tumor area. If you have a small, early lung cancer, this approach may help improve accuracy while limiting how much lung is removed.
Hear when a new Sentinel Lymph Node trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.